NYSEArca - Delayed Quote USD

T. Rowe Price QM U.S. Bond ETF (TAGG)

41.27 -0.11 (-0.26%)
At close: April 18 at 2:02 PM EDT
Loading Chart for TAGG
DELL
  • Previous Close 41.37
  • Open 41.27
  • Bid 41.26 x 800
  • Ask 41.33 x 1000
  • Day's Range 41.27 - 41.27
  • 52 Week Range 39.65 - 43.75
  • Volume 2
  • Avg. Volume 1,438
  • Net Assets 90.86M
  • NAV 41.24
  • PE Ratio (TTM) 1.87
  • Yield 3.90%
  • YTD Daily Total Return -2.93%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.08%

Under normal conditions, the fund will invest at least 80% of its net assets in U.S. bonds. The fund’s overall investment strategy is to provide total returns that exceed the total returns of its benchmark index, the Bloomberg U.S. Aggregate Bond Index. The index is a broadly diversified index that typically consists of investment-grade, fixed income instruments with intermediate- to long-term maturities. The adviser generally invests in a wide range of bonds represented in the index.

T. Rowe Price

Fund Family

Intermediate Core Bond

Fund Category

90.86M

Net Assets

2021-09-28

Inception Date

Performance Overview: TAGG

Trailing returns as of 4/18/2024. Category is Intermediate Core Bond.

YTD Return

TAGG
2.93%
Category
0.51%
 

1-Year Return

TAGG
0.08%
Category
2.01%
 

3-Year Return

TAGG
0.00%
Category
2.45%
 

People Also Watch

Holdings: TAGG

Sector Weightings

SectorTAGG
Technology   50.04%
Healthcare   6.43%
Industrials   4.81%
Utilities   1.23%
Energy   0.50%
Real Estate   0.28%

Related ETF News

Research Reports: TAGG

  • Analyst Report: HCA Healthcare, Inc.

    HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.

    Rating
    Neutral
    Price Target
     
  • Analyst Report: Johnson & Johnson

    Johnson & Johnson is a diversified global healthcare company that develops, manufactures and markets products in two business segments: Innovative Medicine (formerly Pharmaceuticals) and MedTech.

    Rating
    Bullish
    Price Target
     
  • Analyst Report: Monster Beverage Corporation

    Monster Beverage is a leader in the energy drink subsegment of the nonalcoholic beverage market, generating two thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to copackers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster with a 19.5% stake.

    Rating
    Bearish
    Price Target
     
  • Analyst Report: Monster Beverage Corporation

    Monster Beverage is a leader in the energy drink subsegment of the nonalcoholic beverage market, generating two thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to copackers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster with a 19.5% stake.

    Rating
    Neutral
    Price Target